Women and minorities lacking in research and clinical trials for new cardiometabolic medications

Women and minorities have low participation rates in pivotal trials for new medications. 10-year analysis of clinical trial data reveals no improvement in diversity over time. Further efforts are needed to determine differences in medication effects among demographic subgroups.